Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure. | Viruses | 2020 | 32403278 | PubTator, text mining | PubMed |
| Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells. | Aging (Albany NY) | 2020 | 32401230 | PubTator, text mining | PubMed |
| Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery. | Int J Mol Sci | 2020 | 32397434 | PubTator, text mining | PubMed |
| miR-107 inhibited malignant biological behavior of non-small cell lung cancer cells by regulating the STK33/ERK signaling pathway in vivo and vitro. | J Thorac Dis | 2020 | 32395291 | PubTator, text mining | PubMed |
| PD-L1 expression in malignant pleural effusion samples and its correlation with oncogene mutations in non-small cell lung cancer. | J Thorac Dis | 2020 | 32395276 | PubTator, text mining | PubMed |
| CDK7 inhibitors as anticancer drugs. | Cancer Metastasis Rev | 2020 | 32385714 | PubTator, text mining | PubMed |
| A putative competing endogenous RNA network in cisplatin-resistant lung adenocarcinoma cells identifying potentially rewarding research targets. | Oncol Lett | 2020 | 32382346 | PubTator, text mining | PubMed |
| Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms. | Exp Mol Med | 2020 | 32382065 | PubTator, text mining | PubMed |
| Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers. | Infect Agent Cancer | 2020 | 32377232 | PubTator, text mining | PubMed |
| Expression and Prognostic Significance of CDK8 and β-Catenin in Hepatocellular Carcinoma. | In Vivo | 2020 | 32354935 | PubTator, text mining | PubMed |
| Immunomodulation by anticancer cell cycle inhibitors. | Nat Rev Immunol | 2020 | 32346095 | PubTator, text mining | PubMed |
| CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets. | Int J Mol Sci | 2020 | 32344731 | PubTator, text mining | PubMed |
| Genome Editing As an Approach to the Study of in Vivo Transcription Reprogramming. | Dokl Biochem Biophys | 2020 | 32342312 | PubTator, text mining | PubMed |
| De Novo Variants in CDK19 Are Associated with a Syndrome Involving Intellectual Disability and Epileptic Encephalopathy. | Am J Hum Genet | 2020 | 32330417 | PubTator, text mining | PubMed |
| MYC Controls the Epstein-Barr Virus Lytic Switch. | Mol Cell | 2020 | 32315601 | PubTator, text mining | PubMed |
| Enhancer architecture sensitizes cell specific responses to Notch gene dose via a bind and discard mechanism. | Elife | 2020 | 32297857 | PubTator, text mining | PubMed |
| The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases. | Front Immunol | 2020 | 32296421 | PubTator, text mining | PubMed |
| Metabolic labeling of RNA uncovers the contribution of transcription and decay rates on hypoxia-induced changes in RNA levels. | RNA | 2020 | 32295863 | PubTator, text mining | PubMed |
| PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression. | Theranostics | 2020 | 32292506 | PubTator, text mining | PubMed |
| Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis. | Mol Cancer | 2020 | 32278350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=49